Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Org Biomol Chem. 2010 Nov 15;9(1):127–135. doi: 10.1039/c0ob00592d

Table 1.

Inhibitory potency of 3-substituted 2,4-PDCA derivatives against JMJD2E, PHD2 and formaldehyde dehydrogenase

graphic file with name emss-66706-t0006.jpg

Entry Compound Template R JMJD2E
IC50/μMa
JMJD2E Residual
Activity (%)a
PHD2 Residual
Activity (%)b
FDH Residual
Activity (%)c
1 5 A H 0.44 0% 22% 100%
2 33 A Br n.d. 67% 100% 100%
3 34 A Ph n.d. 84% 100% 100%
4 35 A (E)-CH=CHPh 66 25% 85% 87%
5 36 A OPh n.d. 48% 88% 91%
6 37 B NHPh 19 0% 100% 83%
7 38 B NH-p-C6H4-OMe 164 6% 100% 78%
8 39 B NH-p-C6H4-NO2 95 0% 100% 100%
9 40 B NH-p-C6H4-CO2H 66 13% 0% 100%
10 41 B NH-o,p-C6H3-diF 48 12% 100% 100%
11 42 B NH-o-C6H4-SMe 48 5% 100% 80%
12 43 B NH-o-C6H4-CO2H 166 39% 100% 73%
13 44 B NH-o-C6H4-NO2 56 6% 100% 59%
14 45 B NH-o-C6H4-OMe 19 2% 100% 76%
15 46 B NH-o-C6H4-Me 41 3% 100% 79%
16 47 B NH-o-C6H4–F 2.5 d 100% d
17 48 A NH-Naphthyl 26 0% 100% 59%
18 49 A NH-CH2-p-C6H4-OMe 41 29% 71% 100%
19 50 e A NH2 0.11 d 23% d
a

Determined by FDH-coupled assay; enzyme concentration 400 nM; residual activity reported at 200 μM compound concentration.

b

Determined by an HTRF-based assay; enzyme concentration 20 nM; residual activity reported at 400 μM compound concentration.

c

Enzyme concentration 50 μM; spectrophotometric assay; residual activity reported at 200 μM compound concentration.

d

Compound was fluorescent at the tested concentration.

e

Stock solutions prepared at 1 mM concentration because of limited solubility.

HHS Vulnerability Disclosure